Your browser doesn't support javascript.
loading
Remifentanil pretreatment ameliorates H/R-induced cardiac microvascular endothelial cell dysfunction by regulating the PI3K/Akt/HIF-1α signaling pathway.
Li, Xiaojun; Gui, Zhenping; Liu, Huizi; Qian, Shaojie; Jia, Yanan; Luo, Xiaopan.
Afiliação
  • Li X; Department of Anesthesiology, Zhejiang Provincial People's Hospital, Hangzhou City, Zhejiang Province, P.R. China.
  • Gui Z; Department of Anesthesiology, Linan Qingshan Lake Hospital of Traditional Chinese Medicine, Hangzhou City, Zhejiang Province, P.R. China.
  • Liu H; Department of Anesthesiology, Zhejiang Provincial People's Hospital, Hangzhou City, Zhejiang Province, P.R. China.
  • Qian S; Department of Anesthesiology, Zhejiang Provincial People's Hospital, Hangzhou City, Zhejiang Province, P.R. China.
  • Jia Y; Department of Anesthesiology, Zhejiang Provincial People's Hospital, Hangzhou City, Zhejiang Province, P.R. China.
  • Luo X; Department of Anesthesiology, Zhejiang Provincial People's Hospital, Hangzhou City, Zhejiang Province, P.R. China.
Bioengineered ; 12(1): 7872-7881, 2021 12.
Article em En | MEDLINE | ID: mdl-34612779

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiotônicos / Hipóxia Celular / Células Endoteliais / Remifentanil / Miocárdio Limite: Humans Idioma: En Revista: Bioengineered Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiotônicos / Hipóxia Celular / Células Endoteliais / Remifentanil / Miocárdio Limite: Humans Idioma: En Revista: Bioengineered Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos